Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/αvβ6 Bispecfic ADC JSKN022
SUZHOU, China, Oct. 24, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed at Sun Yat-sen University Cancer Center in the phase I clinical study (Study ID: JSKN022-101) of...
Geely Debuts EX5 in the UK, Driving Its Expansion into Europe's Rapidly-Growing EV Segment
LONDON, Oct. 24, 2025 /PRNewswire/ -- Geely Auto today officially launched the Geely EX5, an award-winning all-electric SUV, in the United Kingdom. This launch reinforces Geely Auto's commitment to sustainable mobility and its ambition to become a...
Hesai Secures New Lidar Design Win with a Top 5 Chinese NEV Automaker, Entering Mass Production Phase this Year
PALO ALTO, Calif., March 13, 2025 /PRNewswire/ -- Hesai Technology, a global leader in lidar R&D and manufacturing, has secured a new design win with a top 5 NEV automaker in China. This automaker, part of a major global automotive group, will...